The Antibody Engineering & Therapeutics conference series recently (Aug 2019) conducted a survey of industry professionals from pharma, biotechs, academia, CDMOs, CROs, service providers and consultancies around the world. This report based on 211 responses reveals unique insights into the hottest potential opportunities and the biggest challenges around emerging technologies and novel approaches in antibody engineering and therapeutics. Dan Stanton, Editor of BioProcess Insider, introduces the report with what some of the key takeaways mean for the industry.
To download the exclusive report simply log in or register for an Informa Connect account, which will give you access to all our exclusive premium content.
Have any questions about the report or interested in sponsoring a future report? Email andrew.burrows@informa.com.
Log in or Create an Informa Connect Account to Access this content
Creating an account also means you'll get special access to article updates and exclusive industry content.